期刊文献+

联合用药与复方制剂在高血压治疗中的作用 被引量:7

原文传递
导出
摘要 目前世界各个国家高血压的治疗现状仍不容乐观,高血压的知晓率、治疗率和达标率仍然很低,如何提高"三率"水平是我国高血压防治的主要任务.造成我国高血压"达标率低"的一个重要原因就是高血压用药配伍不合理,使患者未得到有效的治疗.
机构地区 北京协和医学院
出处 《中华全科医师杂志》 2010年第9期598-600,共3页 Chinese Journal of General Practitioners
  • 相关文献

参考文献14

  • 1Chobanian AV,Bakris GL,Black HR,et al.The seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure:the JNC 7 report.JAMA,2003,289:2560 -2572.
  • 2Mancia G,De Backer G,Dominiczak A,et al.2007 guidelines for the management of arterial hypertension:the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).J Hypertens,2007,25:1105-1187.
  • 3刘力生,王文,姚崇华.中国高血压防治指南(2009年基层版)[J].中华高血压杂志,2010,18(1):11-30. 被引量:861
  • 4Liu L,Zhang Y,Liu G,et al.The felodipine event reduction (FEVER) study:a randomized long-term placebo-controlled trial in Chinese hypertensive patients.J Hypertens,2005,23:2157-2172.
  • 5Dahlof B,Sever PS,poulter NR,et al.Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required,in the anglo-scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA):a multicentre randomised controlled trial.Lancet,2005,366:895-906.
  • 6Bakris GL,Sarafidis PA,Weir MR,et al.Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH):a prespecified secondary analysis of a randomised controlled trial.Lancet,2010,375:1173-1181.
  • 7王文,张宇清,马丽媛,刘明波,邓卿,吴海英,黄建风,刘力生,CHIEF研究协作组.CHIEF:中国高血压干预效果研究-初始低剂量钙离子拮抗剂为基础的联合方案治疗高血压的随机临床研究阶段报告-1[J].中国循证心血管医学杂志,2008,1(1):24-27. 被引量:13
  • 8Zoungas S,de Galan BE,Ninomiya T,et al.Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes:new results from the ADVANCE trial.Diabetes Care,2009,32:2068 -2074.
  • 9Mann JF,Schmieder RE,McQueen M,et al.Renal outcomes with telmisartan,ramipril,or both,in people at high vascular risk (the ONTARGET study):a multicentre,randomised,double-blind,controlled trial.Lancet,2008,372:547-553.
  • 10Devereux RB,de Faire U,Fyhrquist F,et al.Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.Curr Med Res Opin,2007,23:259-270.

二级参考文献1

共引文献872

同被引文献77

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部